Assignee profile:

GENVEC, INC.

City:

Gaithersburg, Maryland

Country:

United States

Published Applications:

76

Last publication date:

2021-09-30

Patent Grants:

43

Last grant date:

2022-06-14

Top Inventors for applications by GENVEC, INC.

These are the the leading inventors for applications assigned to GENVEC, INC.:

Recent patent applications by GENVEC, INC.

GENVEC, INC. based in Gaithersburg, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-09-30
US20210301303A1
Chemistry; metallurgy

ADENOVECTORS FOR DELIVERY OF THERAPEUTIC GENETIC MATERIAL INTO T CELLS

#2 | 2021-09-02
US20210269827A1
Chemistry; metallurgy

MODIFIED SEROTYPE 28 ADENOVIRAL VECTORS

#3 | 2021-02-11 ✅ Patent 11,359,214 granted on 2022-06-14
US20210040502A1
Chemistry; metallurgy

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

#4 | 2019-10-17 ✅ Patent 11,034,975 granted on 2021-06-15
US20190316152A1
Chemistry; metallurgy

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

#5 | 2019-09-05 ✅ Patent 10,792,376 granted on 2020-10-06
US20190269794A1
Human necessities

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

#6 | 2019-08-15 ✅ Patent 10,780,153 granted on 2020-09-22
US20190247483A1
Human necessities

Malaria antigens and methods of use

#7 | 2019-08-01 ✅ Patent 11,155,832 granted on 2021-10-26
US20190233845A1
Chemistry; metallurgy

Adenovectors for delivery of therapeutic genetic material into T cells

#8 | 2019-04-04
US20190100561A1
Chemistry; metallurgy

HERPES SIMPLEX VIRUS VACCINE

#9 | 2019-02-21 ✅ Patent 10,787,682 granted on 2020-09-29
US20190055579A1
Chemistry; metallurgy

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

#10 | 2018-12-06 ✅ Patent 10,314,901 granted on 2019-06-11
US20180344833A1
Human necessities

Malaria antigens and methods of use

#11 | 2018-08-09 ✅ Patent 10,640,776 granted on 2020-05-05
US20180223290A1
Chemistry; metallurgy

Method for propagating adenoviral vectors encoding inhibitory gene products

#12 | 2018-07-26 ✅ Patent 11,279,951 granted on 2022-03-22
US20180208944A1
Chemistry; metallurgy

Adenoviral vector encoding human atonal homolog-1 (HATH1)

#13 | 2018-06-07 ✅ Patent 10,022,432 granted on 2018-07-17
US20180153979A1
Human necessities

Malaria antigens and methods of use

#14 | 2018-04-12 ✅ Patent 10,947,560 granted on 2021-03-16
US20180100164A1
Chemistry; metallurgy

Modified serotype 28 adenoviral vectors

#15 | 2018-03-08 ✅ Patent 10,260,074 granted on 2019-04-16
US20180066281A1
Chemistry; metallurgy

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

#16 | 2017-09-28 ✅ Patent 10,125,174 granted on 2018-11-13
US20170275339A1
Chemistry; metallurgy

Herpes simplex virus vaccine

#17 | 2017-08-31 ✅ Patent 10,272,162 granted on 2019-04-30
US20170246318A1
Human necessities

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

#18 | 2017-08-03 ✅ Patent 10,188,721 granted on 2019-01-29
US20170216422A1
Human necessities

Recombinant adenovirus vectored FMDV vaccines and uses thereof

#19 | 2017-07-27 ✅ Patent 10,059,962 granted on 2018-08-28
US20170211097A1
Chemistry; metallurgy

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

#20 | 2016-10-20
US20160304882A1
Chemistry; metallurgy

METHOD FOR PROPAGATING ADENOVIRAL VECTORS ENCODING INHIBITORY GENE PRODUCTS

#21 | 2016-05-05 ✅ Patent 9,725,738 granted on 2017-08-08
US20160122781A1
Chemistry; metallurgy

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

#22 | 2016-04-14 ✅ Patent 9,951,351 granted on 2018-04-24
US20160102320A1
Chemistry; metallurgy

Adenoviral vector encoding human atonal homolog-1 (HATH1)

#23 | 2015-11-19 ✅ Patent 9,586,998 granted on 2017-03-07
US20150329834A1
Chemistry; metallurgy

Methods of propagating monkey adenoviral vectors

#24 | 2015-10-22 ✅ Patent 9,833,502 granted on 2017-12-05
US20150297699A1
Human necessities

Malaria antigens and methods of use

#25 | 2015-06-18 ✅ Patent 9,790,519 granted on 2017-10-17
US20150167018A1
Chemistry; metallurgy

Modified serotype 28 adenoviral vectors

#26 | 2015-05-21 ✅ Patent 9,676,824 granted on 2017-06-13
US20150140025A1
Chemistry; metallurgy

Herpes simplex virus vaccine

#27 | 2014-10-23 ✅ Patent 9,617,560 granted on 2017-04-11
US20140314717A1
Chemistry; metallurgy

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

#28 | 2014-09-18 ✅ Patent 9,388,429 granted on 2016-07-12
US20140273228A1
Chemistry; metallurgy

Method for propagating adenoviral vectors encoding inhibitory gene products

#29 | 2014-09-18 ✅ Patent 9,580,476 granted on 2017-02-28
US20140271711A1
Chemistry; metallurgy

Adenoviral vector-based respiratory syncytial virus (RSV) vaccine

#30 | 2014-09-04 ✅ Patent 9,629,906 granted on 2017-04-25
US20140248308A1
Human necessities

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

#31 | 2014-09-04 ✅ Patent 9,233,153 granted on 2016-01-12
US20140248307A1
Human necessities

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

#32 | 2014-01-02
US20140005257A1
Human necessities

METHODS OF GENE THERAPY FOR TREATING DISORDERS OF THE EAR BY ADMINISTERING A VECTOR ENCODING AN ATONAL-ASSOCIATED FACTOR

#33 | 2013-12-19 ✅ Patent 8,920,813 granted on 2014-12-30
US20130337008A1
Human necessities

Adenoviral vector-based dengue fever vaccine

#34 | 2012-12-13
US20120316226A1
Human necessities

METHODS OF GENE THERAPY FOR TREATING DISORDERS OF THE EAR BY ADMINISTERING A VECTOR ENCODING AN ATONAL-ASSOCIATED FACTOR

#35 | 2012-11-29
US20120302627A1
Chemistry; metallurgy

METHOD OF USING ADENOVIRAL VECTORS TO INDUCE AN IMMUNE RESPONSE

#36 | 2012-09-06 ✅ Patent 9,133,248 granted on 2015-09-15
US20120225470A1
Chemistry; metallurgy

Methods of propagating monkey adenoviral vectors

#37 | 2012-08-09
US20120203052A1
Human necessities

THERAPEUTIC REGIMEN FOR TREATING CANCER

#38 | 2012-05-17
US20120123186A1
Chemistry; metallurgy

THERAPEUTIC REGIMEN FOR TREATING CANCER

#39 | 2011-11-10 ✅ Patent 8,323,961 granted on 2012-12-04
US20110274721A1
Human necessities

HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

#40 | 2011-08-18 ✅ Patent 8,454,972 granted on 2013-06-04
US20110200636A1
Human necessities

Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen

#41 | 2011-05-26
US20110123569A1
Human necessities

VACCINE DIRECTED AGAINST ADENOVIRUS SEROTYPE 14

#42 | 2011-02-10
US20110034752A1
Chemistry; metallurgy

THERAPEUTIC REGIMEN FOR TREATING CANCER

#43 | 2010-12-02
US20100305199A1
Human necessities

THERAPEUTIC REGIMEN FOR TREATING CANCER

#44 | 2009-11-19
US20090286860A1
Chemistry; metallurgy

Method of using adenoviral vectors to induce an immune response

#45 | 2009-10-22 ✅ Patent 8,323,663 granted on 2012-12-04
US20090264509A1
Human necessities

Adenoviral vector-based foot-and-mouth disease vaccine

#46 | 2009-06-11
US20090149381A1
Human necessities

Methods of regulating angiogenesis through stabilization of PEDF

#47 | 2009-06-11 ✅ Patent 8,765,146 granted on 2014-07-01
US20090148477A1
Chemistry; metallurgy

Adenoviral vector-based malaria vaccines

#48 | 2009-02-12
US20090041759A1
Human necessities

Materials and methods for treating ocular-related disorders

#49 | 2009-01-15
US20090018100A1
Chemistry; metallurgy

MATERIALS AND METHODS FOR TREATING OCULAR-RELATED DISORDERS

#50 | 2008-10-09
US20080248060A1
Human necessities

ADENOVIRAL VECTOR-BASED MALARIA VACCINES

#51 | 2008-09-25
US20080233650A1
Chemistry; metallurgy

Method for propagating adenoviral vectors encoding inhibitory gene products

#52 | 2008-03-20
US20080069836A1
Chemistry; metallurgy

METHOD OF USING ADENOVIRAL VECTORS WITH INCREASED IMMUNOGENICITY IN VIVO

#53 | 2008-01-03
US20080003236A1
Human necessities

ADENOVIRUS FIBER SHAFT COMPOSITION AND METHODS OF USE

#54 | 2007-10-04
US20070232541A1
Human necessities

METHODS OF REGULATING ANGIOGENISIS THROUGH STABILIZATION OF PEDF

#55 | 2007-09-06
US20070207166A1
Chemistry; metallurgy

Method of Using Adenoviral Vectors to Induce an Immune Response

#56 | 2007-07-19
US20070166284A1
Human necessities

THERAPEUTIC REGIMEN FOR TREATING CANCER

#57 | 2007-06-21
US20070141029A1
Human necessities

Methods of gene therapy for treating disorders of the ear by adminstering a vector encoding an antonal-associated factor

#58 | 2007-05-08 ✅ Patent 7,214,368 granted on 2007-05-08
US10151633
-

Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene

#59 | 2007-05-03
US20070098692A1
Chemistry; metallurgy

MATERIALS AND METHODS FOR TREATING OCULAR-RELATED DISORDERS

#60 | 2007-03-27 ✅ Patent 7,195,896 granted on 2007-03-27
US9964065
-

Complementary adenoviral vector systems and cell lines

#61 | 2006-11-28 ✅ Patent 7,141,406 granted on 2006-11-28
US10429303
-

Efficient purification of adenovirus

#62 | 2006-11-16
US20060257369A1
Chemistry; metallurgy

Therapeutic regimen for treating cancer

#63 | 2006-07-04 ✅ Patent 7,070,930 granted on 2006-07-04
US10162043
-

Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus

#64 | 2006-06-29
US20060140909A1
Chemistry; metallurgy

Method of using adenoviral vectors with increased persistence in vivo

#65 | 2006-02-14 ✅ Patent 6,998,263 granted on 2006-02-14
US9780526
-

Methods of preparing and using a viral vector library

#66 | 2005-12-15
US20050277193A1
Chemistry; metallurgy

Vectors and methods for gene transfer

#67 | 2005-11-24
US20050260180A1
Chemistry; metallurgy

Materials and methods for treating vascular leakage in the eye

#68 | 2005-10-06
US20050220768A1
Human necessities

Materials and methods for treating ocular-related disorders

#69 | 2005-10-04 ✅ Patent 6,951,755 granted on 2005-10-04
US9999724
-

Vectors and methods for gene transfer

#70 | 2005-09-06 ✅ Patent 6,939,540 granted on 2005-09-06
US9629074
-

Method of enhancing bone density

#71 | 2005-09-01
US20050191278A1
Chemistry; metallurgy

Coronary artery disease treatment

#72 | 2005-07-05 ✅ Patent 6,913,927 granted on 2005-07-05
US10695605
-

Non-adenoviral gene product-based complementing cells for adenoviral vectors

#73 | 2005-06-21 ✅ Patent 6,908,762 granted on 2005-06-21
US10427759
-

Method of preparing a eukaryotic viral vector

#74 | 2005-06-16
US20050130219A1
Chemistry; metallurgy

Method of identifying a gene product

#75 | 2005-05-12
US20050101018A1
Chemistry; metallurgy

Viral vector encoding pigment epithelium-derived factor

#76 | 2005-03-01 ✅ Patent 6,861,229 granted on 2005-03-01
US10336702
-

Method of identifying a gene product

Also check out GenVec, Inc.'s (Gaithersburg, United States) applicant profile with 28 patent applications submitted.

AssigneeID:

49144 ⎘